Unique ID issued by UMIN | UMIN000013205 |
---|---|
Receipt number | R000015407 |
Scientific Title | Prospective multicenter study on efficacy of the mediastinal and para-aortic lymph node dissection for esophagogastric junction cancer. |
Date of disclosure of the study information | 2014/02/20 |
Last modified on | 2020/02/25 16:17:22 |
Prospective multicenter study on efficacy of the mediastinal and para-aortic lymph node dissection for esophagogastric junction cancer.
Prospective study on efficacy of lymph node dissection for EGJ cancer.
Prospective multicenter study on efficacy of the mediastinal and para-aortic lymph node dissection for esophagogastric junction cancer.
Prospective study on efficacy of lymph node dissection for EGJ cancer.
Japan |
Esophagogastric junction cancer
Gastrointestinal surgery |
Malignancy
NO
To invastigate the metastasis rates of mediastinal and para-aortic lymph nodes in the resectable cT2-T4 esophagogastric cancer.
Safety,Efficacy
Exploratory
Metastasis rates of the respective lymph nodes
Recurrence-free survival, Overall survival, Therapeutic value index calculated by multiplication of the metastasis rate by the 5-year overall survival rate in patients with metastasis in the respective nodes, R0 resection rate, Postoperative complications, Sites of recurrence
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Thorough mediastinal and para-aortic lymph node dissection via a transthoracic approach, or lower mediastinal and para-aortic lymph node dissection via a transhiatal approach
20 | years-old | <= |
Not applicable |
Male and Female
1) An epicenter of tumor locates within 2cm of the esophagogastric junction.
2) Histologicall proven adenocarcinoma, squamous cell carcinoma, or adenosquamous carcinoma.
3) cT2-T4.
4) Resectable.
5) Age of 20 years or older.
6) ECOG performance status of 0 or 1.
7) Adequate organ function as follows:
WBC >=3,000/mm3, Hemoglobin >=8.0 g/dL, Platelet >=75,000/mm3, Total bilirubin <=3.0 mg/dL, Creatinine <=2.0 mg/dL.
8) Written informed consent.
1) Prior history of gastrectomy.
2) Cannot perform the surgery prerescribed in the protocol.
360
1st name | Yuichiro |
Middle name | |
Last name | Doki |
Osaka University Graduate School of Medicine
Department of Gastroenterological Surgery
565-0871
2-2-E2, Yamadaoka, Suita, Osaka, Japan
06-6879-3251
ydoki@gesurg.med.osaka-u.ac.jp
1st name | Yukinori |
Middle name | |
Last name | Kurokawa |
Osaka University Graduate School of Medicine
Department of Gastroenterological Surgery
565-0871
2-2-E2, Yamadaoka, Suita, Osaka, Japan
06-6879-3251
ykurokawa@gesurg.med.osaka-u.ac.jp
Working Group of Japanese Gastric Cancer Association and Japan Esophageal Society
Nothing
Self funding
IRB, Osaka University Hospital
2-15, Yamadaoka, Suita, Osaka
06-6210-8295
rinri@hp-crc.med.osaka-u.ac.jp
NO
大阪大学、獨協医科大学、九州がんセンター、大阪府立成人病センター、愛知県がんセンター、四国がんセンター、近畿大学、新潟県立がんセンター新潟病院、徳島大学、千葉大学、群馬大学、鹿児島大学、倉敷中央病院、関西労災病院、静岡県立静岡がんセンター、慶應義塾大学、京都府立医科大学、埼玉県立がんセンター、大阪府立急性期・総合医療センター、東邦大学、京都第一赤十字病院、岐阜大学、神奈川県立がんセンター、岡山大学、名古屋大学、広島市民病院、川崎医科大学、横浜市立大学附属市民総合医療センター、熊本大学、大阪医療センター、がん研究会有明病院、東京大学、虎の門病院、東京医科歯科大学、国立がん研究センター東病院、北里大学、兵庫医科大学、東海大学、都立駒込病院、埼玉医科大学、自治医科大学、国際医療研究センター
2014 | Year | 02 | Month | 20 | Day |
Partially published
371
Main results already published
2014 | Year | 02 | Month | 13 | Day |
2014 | Year | 02 | Month | 13 | Day |
2014 | Year | 02 | Month | 21 | Day |
2022 | Year | 12 | Month | 31 | Day |
2014 | Year | 02 | Month | 20 | Day |
2020 | Year | 02 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015407
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |